A virtual-first platform for chronic GI conditions including IBS, GERD, dyspepsia, + Celiac that affect over 60M Americans, Salvo offers RPM enablement to GI groups to drive new revenue and improve outcomes, with nutrition, GI-psychology, advanced lab testing, & behavioral health support. This frees GI's to practice at the top of their license. Salvo also helps payers + ACO's improve outcomes at lower system cost via value-based specialty care. Salvo is backed by $10.5M from top health VCs.